Vascular access site complications after percutaneous coronary intervention with abciximab in the Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples